Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
Insider tradingForm 4

Anixa Biosciences Inc (ANIX) Insider Trading

9 open-market trades reported since Sep 11, 2026: 9 purchases worth $276K and 0 sales worth $0.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Lewis H. Titterton JrDirector3$183K0$0Oct 26, 2026
Amit KumarCEO4$63K0$0Oct 22, 2026
Michael CatelaniCFO1$16K0$0Sep 30, 2026
Arnold M. BaskiesDirector1$14K0$0Sep 28, 2026
ADVERTISEMENT
728 × 90 ad slot320 × 100 ad slot

All trades

ANIX insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Oct 26Oct 23Lewis H. Titterton JrDirectorDirector▲ BUY8,0002.98$24K+0.8%Form 4 ↗
Oct 22Oct 22Amit KumarCEOCEO▲ BUY8,0002.72$22K+1.2%Form 4 ↗
Sep 30Sep 30Michael CatelaniCFOCFO▲ BUY5,5002.84$16K+12%Form 4 ↗
Sep 28Sep 24Amit KumarCEOCEO▲ BUY7,0002.78$19K+1.1%Form 4 ↗
Sep 28Sep 24Arnold M. BaskiesDirectorDirector▲ BUY5,0002.76$14K+3.7%Form 4 ↗
Sep 25Sep 23Lewis H. Titterton JrDirectorDirector▲ BUY49,0362.69$132K+4.9%Form 4 ↗
Sep 14Sep 10Lewis H. Titterton JrDirectorDirector▲ BUY10,0002.73$27K+1.0%Form 4 ↗
Sep 14Sep 10Amit KumarCEOCEO▲ BUY3,0002.75$8K+0.5%Form 4 ↗
Sep 11Sep 10Amit KumarCEOCEO▲ BUY5,0002.76$14K+0.8%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings